Lumiera Health Inc
XTSX:NHP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Lumiera Health Inc
Free Cash Flow
Lumiera Health Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Lumiera Health Inc
XTSX:NHP
|
Free Cash Flow
-$1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Free Cash Flow
CA$18.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Free Cash Flow
-CA$86.7m
|
CAGR 3-Years
46%
|
CAGR 5-Years
36%
|
CAGR 10-Years
-11%
|
|
|
OrganiGram Holdings Inc
TSX:OGI
|
Free Cash Flow
-CA$36.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-20%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Free Cash Flow
CA$58.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Free Cash Flow
-$190k
|
CAGR 3-Years
87%
|
CAGR 5-Years
75%
|
CAGR 10-Years
22%
|
|
Lumiera Health Inc
Glance View
Lumiera Health, Inc. engages in the commercialization and development of evidence-based botanical products for the healthcare and bio-agriculture. The company is headquartered in Montreal, Quebec. The company went IPO on 2013-11-14. The firm is focused on selling natural products as well as the development and commercialization of botanical-based products for human health care. The firm also operates as product development, marketing and sales business of natural products. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The firm is also providing solutions for chronic pain and inflammation. The company is also helping people to improve health by delivering products. The Company’s subsidiary is Holizen Laboratory Inc.
See Also
What is Lumiera Health Inc's Free Cash Flow?
Free Cash Flow
-1.2m
USD
Based on the financial report for Nov 30, 2022, Lumiera Health Inc's Free Cash Flow amounts to -1.2m USD.
What is Lumiera Health Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
32%
Over the last year, the Free Cash Flow growth was 32%.